SCHEMBL22758542

SCHEMBL22758542

COC(=O)C1(c2ccnc(S(C)(=O)=O)n2)CCS(=O)(=O)CC1

nearest known ligand 0.33

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CTPS1 P17812 1/20 0.33
▸ MEN1 O00255 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ TLR9 Q9NR96 1/20 0.31
▸ IRAK4 Q9NWZ3 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ CCNT1 O60563 1/20 0.31
▸ CDK9 P50750 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ MMP1 P03956 1/20 0.30
▸ MMP13 P45452 1/20 0.30
▸ PDE4B Q07343 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22758543 0.88 NPSR1 (0.33) CTPS1MEN1NPC1RAB9AKMT2A
SCHEMBL21392084 0.84 CYP3A4 (0.41) CTPS1MEN1NPC1RAB9AKMT2A
SCHEMBL24848890 0.82 PDE4B (0.33) CTPS1PDE4B
SCHEMBL22762471 0.81 L3MBTL1 (0.34) MEN1KMT2AIRAK4ALDH1A1PDE4B
SCHEMBL22758464 0.78 CTPS1 (0.49) CTPS1
SCHEMBL24849581 0.78 MMP2 (0.33) NPC1RAB9ATLR9IRAK4NPSR1
SCHEMBL21373824 0.70 IDO1 (0.35) NPSR1ALDH1A1
SCHEMBL21373841 0.70 TRPV1 (0.36) ALDH1A1
SCHEMBL22758534 0.69 IDO1 (0.35) MEN1KMT2ANPSR1ALDH1A1
SCHEMBL17601111 0.68 IDH1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020245664-A1 N-(5-(6-ETHOXYPYRAZIN-2-YL)PYRIDIN-2-YL)-4-(2-(METHYLSULFONAMIDO)PYRIMIDIN-4-YL) TETRAHYDRO-2H-PYRAN-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS HUMAN CTPS1 INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES STEP PHARMA S.A.S. (FR) 2020-12-10 — — WO disclosed
Send feedback